A Winning Wednesday, 5 Fresh Picks

Wednesday’s Winners:

In yesterday morning’s premarket report, we placed a trio of potential options trading ideas on watch, and were pleased with the intraday performances on all three of them. Generally, we don’t often miss on our quick-strike (weekly expiration) ideas. We like to occasionally mix in longer-term swing trade ideas that may take awhile to come to fruition, but our strongest suit is definitely ID’ing plays for ‘today’ on any given day.

Yesterday’s plays were the PDD Weekly $149-152.50 Calls, the GIS Weekly $71-72 Calls, and the INTC Weekly $42.50-43.50 Calls, and all three sets of calls fared rather well. Here were the performances they laid down:

PDD Weekly $149-152.50 Calls
$149
: .32-.72 (+125%)
$150: .19-.35 (+84%)
$152.50: .25-.46 (+84%)
_____

GIS Weekly $71-72 Calls
$71
: .70-1.50 (+114%)
$72: .37-.90 (+143%)
_____

INTC Weekly $42.50-43.50 Calls
$42.50: .49-.81 (+65%)
$43: .37-.61 (+65%)
$43.50: .26-.45 (+73%)


Fresh Options Ideas:
SPY 03/21 $522-523 Calls*
MU Weekly $111-113 Calls
ACN Weekly $357.50-350 Puts
DRI 04/19 $170-165 Puts
CHWY Weekly $17-16.50 Puts

*Only experienced traders should attempt to trade options contracts on their day of expiration


Extended Watchlist:
ASST, KAVL, LU, YTEN, LASE, CURI, GOEV, IGPK, SPZI, LQMT

CBIH to Begin Clinical Trials, Options Review & 3 New Ideas

Cannabis Bioscience International Holdings, Inc. (OTCMKTS:CBIH) – News Alert:

We’ve got another fresh PR from CBIH to hit the wires this morning, and it concerns one of the primary topics that was featured in our initial report on the company, Orthocann. It’s a cannabinoid-based knee injection for sufferers of chronic osteoarthritis, and it appears set to undergo clinical trials, per the following announcement:

HOUSTON, TX–(Newsfile Corp. – March 20, 2024) – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) has announced the enrollment of the first patient for the clinical trial of its new intra-articular cannabinoid-based injection for knee osteoarthritis. The company plans to test the product on its first participant, and after careful collection and analysis of clinical outcomes, start enrollment of a bigger sample of patients to administer the treatment and further evaluate its efficacy. (>>View Full PR)

For more information on CBIH, please visit cbih.net
and/or contact Peter Nicosia at (585) 703-6565 with any inquiries


Successful Options Review:

Yesterday’s session turned out pretty well for the potential options trading targets that we mentioned in our premarket report. Two out of the three ideas produced some nice intraday movement, while the third was a set of May contracts that we may yet return to for an update. Speaking of which, in addition to outlining yesterday’s gainers, we also have a couple of longer-term ideas that we formulated in recent reports for which we’ll provide a recap.

Yesterday’s runners were the STNE Weekly $16.50-15.50 Puts, and the DLO 04/19 $16-15 Puts, and the last two updates, on the SAIC 04/19 $135-130 Puts and the ADM 04/19 $57.50-60 Calls have links to the reports in which we first alerted on them.

STNE Weekly $16.50-15.50 Puts
$16.50
: .33-.53 (+61%)
$16: .15-.26 (+73%)
$15.50: .07-.15 (+114%)
_____

DLO 04/19 $16-15 Puts
$16: 1.00-1.52 (+52%)
$15: .60-1.00 (+67%)
_____

SAIC 04/19 $135-130 Puts (Alerted on 03/18)
$135: 6.26-9.75 (+56%)
$130: 2.73-5.20 (+90%)
_____

ADM 04/19 $57.50-60 Calls (Alerted on 03/11)
$57.50: 2.15-4.31 (+101%)
$60: 1.04-2.56 (+146%)


Fresh Options Ideas:
PDD Weekly $149-152.50 Calls
GIS Weekly $71-72 Calls
INTC Weekly $42.50-43.50 Calls


Extended Watchlist:
OBLG, JAGX, MGRX, ETAO, TGL, ENSV, TSHA, IGPK, BCEL, OPTI

Monday’s Performance, 3 New Possibilities

A Good Start to the Week:

All in all, it was a good start to the fresh trading week on Monday. Our premarket report contained two quick-strike options ideas, and a couple of longer-term suggestions. Out of those four possible plays, three of them produced immediate results for us, putting up some nice intraday upswings.

Those targets were the SPY 03/18 $512-513 Calls, the TSLA Weekly $167.50-170 Calls and the ERJ 04/19 $25 Calls. Below are the intraday increases they recorded:

SPY 03/18 $512-513 Calls
$512
: 2.32-3.63 (+56%)
$513: .19-.44 (+132%)
_____

TSLA Weekly $167.50-170 Calls
$167
: 3.60-8.95 (+149%)
$170: 2.63-7.15 (+172%)
_____

ERJ 04/19 $25 Calls
$25: .25-.65 (+160%)


Fresh Options Ideas:
STNE Weekly $16.50-15.50 Puts
DLO 04/19 $16-15 Puts
TMP 05/17 $45-50 Calls


Li-Cycle Holdings Corp. (NYSE:LICY) – Recap: 

We’ve been tracking LICY since the morning of the 13th, and in that time, the stock has made quite a nice move in a positive direction. From its low of .6537 on the morning of our initial report, the stock has gone on to hit 1.50 in premarket trading this morning. That represents an observed run of 129% for us in just the past five trading days.


Extended Watchlist:
IHRT, HIVE, IGPK, MJNA, OTRK, ZCAR, ENVB, FUSN, HOTH, CERS